Group One Trading, L.P. Harpoon Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.55 - $0.82 $2,116 - $3,155	3,848 New	3,848 $2,000
Q3 2022 Nov 09, 2022	BUY	$0.94 - $2.56 $1,316 - $3,584	1,400 Added 790.96%	1,577 $2,000
Q4 2021 Feb 11, 2022	BUY	$5.69 - $7.83 $34 - $46	6 Added 3.51%	177 $1,000
Q3 2021 Nov 12, 2021	SELL	$7.88 - $14.0 $2,364 - $4,200	-300 Reduced 63.69%	171 $1,000
Q2 2021 Aug 10, 2021	SELL	$13.81 - $23.25 $12,069 - $20,320	-874 Reduced 64.98%	471 $7,000
Q1 2021 May 12, 2021	BUY	$17.65 - $24.16 $23,739 - $32,495	1,345 New	1,345 $28,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.